Product description
Tirzepatide is a synthetic 39-amino acid linear peptide engineered as a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is one of the most extensively published compounds in contemporary metabolic research.
Primary research focus
-
Dual GIP/GLP-1 Agonism
Researched for its synergistic action on synergistic incretin pathways.
-
Glycemic Regulation
Evaluated in diabetes and metabolic models for glucose-dependent insulin secretion and glucagon suppression.
-
Appetite & Weight Homeostasis
Studied in relation to delayed gastric emptying and central satiety signaling mechanisms.

